"Syrentis Clinical Research is a multi-specialty clinical research institute which conducts clinical trials in the Santa Ana, CA, area."

During the past decade, Syrentis Clinical Research conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 30 clinical trials were completed, i.e. on average, 48.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 28 clinical trials were completed. i.e. 107.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Syrentis Clinical Research" #1 sponsor was "Allergan" with 6 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Biogen" with 4 trials sponsored and "Avid Radiopharmaceuticals" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Syrentis Clinical Research" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Syrentis Clinical Research" are "Alzheimer Disease" (20 trials), "Alzheimer's Disease" (9 trials), "Gastroparesis" (5 trials), "Mild Cognitive Impairment" (5 trials) and "Depressive Disorder, Major" (4 trials). Many other conditions were trialed in "Syrentis Clinical Research" in a lesser frequency.

Most popular intervention types in "Syrentis Clinical Research" are "Drug" (58 trials), "Other" (6 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Relamorelin" (4 trials), "Donanemab" (3 trials), "Aducanumab" (2 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Syrentis Clinical Research" are 64 trials for "All" genders.

Currently, there are NaN active trials in "Syrentis Clinical Research". undefined are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Syrentis Clinical Research, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Syrentis Clinical Research, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".